Actinium Pharmaceuticals
ATNM
ATNM
30 hedge funds and large institutions have $5.2M invested in Actinium Pharmaceuticals in 2016 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 6 increasing their positions, 6 reducing their positions, and 1 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
more ownership
Funds ownership: →
0% more repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 6
36% less capital invested
Capital invested by funds: $8.12M → $5.2M (-$2.92M)
Holders
30
Holding in Top 10
–
Calls
$234K
Puts
$70K
Top Buyers
| 1 | +$392K | |
| 2 | +$159K | |
| 3 | +$79.5K | |
| 4 |
VKH
Virtu KCG Holdings
New York
|
+$51K |
| 5 |
Nomura Holdings
Tokyo,
Japan
|
+$41K |
Top Sellers
| 1 | -$222K | |
| 2 | -$45.8K | |
| 3 | -$44.3K | |
| 4 |
Balyasny Asset Management
Chicago,
Illinois
|
-$34K |
| 5 |
Group One Trading
Chicago,
Illinois
|
-$15.2K |